• Skip to main content

Parkinson’s Treatment Report

www.ParkinsonsTreatmentReport.com

IPT803

Study to Investigate the Effect of IPT803 Adjunct Treatment in Patients With Parkinson’s Disease

September 4, 2019

https://clinicaltrials.gov/ct2/show/NCT03407378?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=08%2F05%2F2019&lupd_d=14&sort=nwst

A Proof of Concept Study to Investigate the Effect of IPT803 Adjunct Treatment in Patients With Parkinson’s Disease

STUDY TITLE:
A Study to Investigate a New Treatment in Patients With Parkinson’s Disease

DESCRIPTION:
Condition:   Parkinson Disease
Interventions:   Drug: IPT803;   Genetic: Optional pharmacogenetic assessment;   Other: Questionnaires;   Other: Optional Blood-Oxygen-level Dependent functionalMRI;   Other: Motor Assessments before taking regular PD treatment;   Other: Motor Assessments on regular PD treatment
Sponsor:   Tools4Patient
Recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT03407378

FIRST POSTED:
Tue, 23 Jan 2018 12:00:00 EST

LAST UPDATE POSTED:
08/19/19 10:02AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03407378?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=08%2F05%2F2019&lupd_d=14&sort=nwst

Powered by Urgent Research

Copyright © 2025 Urgent Research